These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26011469)

  • 21. Plasma high-density lipoprotein concentrations in chronic-hemodialysis and renal-transplant patients.
    Bagdade JD; Albers JJ
    N Engl J Med; 1977 Jun; 296(25):1436-9. PubMed ID: 194152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis.
    Gugliucci A; Kinugasa E; Kotani K; Caccavello R; Kimura S
    Clin Chem Lab Med; 2011 Jan; 49(1):61-7. PubMed ID: 20961187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure.
    Kimak E; Ksiazek A; Solski J
    Clin Chem Lab Med; 2006; 44(1):64-9. PubMed ID: 16375588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
    Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
    Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.
    Ansari MR; Maheshwari N; Shaikh MA; Laghari MS; ; Lal K; Ahmed K
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):21-5. PubMed ID: 22237213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.
    Mangé A; Goux A; Badiou S; Patrier L; Canaud B; Maudelonde T; Cristol JP; Solassol J
    PLoS One; 2012; 7(3):e34107. PubMed ID: 22470525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes.
    Krishnan S; Shimoda M; Sacchi R; Kailemia MJ; Luxardi G; Kaysen GA; Parikh AN; Ngassam VN; Johansen K; Chertow GM; Grimes B; Smilowitz JT; Maverakis E; Lebrilla CB; Zivkovic AM
    Sci Rep; 2017 Mar; 7():43728. PubMed ID: 28287093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the individual phospholipids and their fatty acids in serum and high-density lipoprotein of the renal patient on long-term maintenance hemodialysis.
    Chapkin RS; Haberstroh B; Liu T; Holub BJ
    J Lab Clin Med; 1983 May; 101(5):726-35. PubMed ID: 6833842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum amyloid A in uremic HDL promotes inflammation.
    Weichhart T; Kopecky C; Kubicek M; Haidinger M; Döller D; Katholnig K; Suarna C; Eller P; Tölle M; Gerner C; Zlabinger GJ; van der Giet M; Hörl WH; Stocker R; Säemann MD
    J Am Soc Nephrol; 2012 May; 23(5):934-47. PubMed ID: 22282592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum high density lipoprotein in hemodialysis patients.
    Unoki T
    Jpn Circ J; 1978 Jul; 42(7):855-64. PubMed ID: 213623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans.
    Montazerifar F; Hashemi M; Karajibani M; Dikshit M
    J Med Food; 2010 Dec; 13(6):1490-3. PubMed ID: 21091256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particles.
    Vekic J; Zeljkovic A; Bogavac-Stanojevic N; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Simic-Ogrizovic S; Dopsaj V; Spasic S
    Clin Biochem; 2011 Jun; 44(8-9):635-41. PubMed ID: 21320480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
    Moradi H; Pahl MV; Elahimehr R; Vaziri ND
    Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipase.
    Dautin G; Soltani Z; Ducloux D; Gautier T; Pais de Barros JP; Gambert P; Lagrost L; Masson D
    Kidney Int; 2007 Oct; 72(7):871-8. PubMed ID: 17667986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.